- Company launches new line of brain-boosting drinks
- Improved formulation includes lion’s mane mushroom, credited for positive effects on cognitive decline
- Clinical trial of Koios drinks underway, results expected soon
- Global functional beverage market to reach $105.5 billion by 2021
Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF), a developer of products designed to boost brain function and productivity, has launched the first two flavors in a new line of beverages that has been flying off the shelves. Pear guava has proven so popular that the company is in its second run of production. The other flavor is peach mango. Both beverages include the new superfood lion’s mane mushroom, which is part of Koios’ reformulated and improved range of cognitive-enhancing drinks. Other flavors soon to come in the same line are blood orange and apricot vanilla.
Lion’s mane mushroom has long been credited in Asian countries for its positive effects on cognitive decline, anxiety and depression, and numerous studies have been conducted to assess these benefits (http://cnw.fm/HR02f). In addition to improving cognitive function, this mushroom has a positive effect on digestive tract health, cardiac function, diabetes management and more.
Denver-based Koios is a growing presence in the field of nootropics, or over-the-counter dietary supplements that enhance cognitive function. Its proprietary GMP-certified formula is designed to enhance focus by increasing blood flow to the brain. Higher oxygen levels in the brain create higher levels of cognition, enhanced functionality and improved mood. Koios’ products contain nature-based ingredients that are typically used to treat people with Alzheimer’s disease.
The launch of Koios’ new line of beverages comes as the company expects clinical trial results of its products to be released any day. NeuraPerformance/Neuroptimize Brain Center, a brain lab and physiotherapy clinic in Denver, Colorado, that is trusted by professional athletes including the Denver Broncos football team, was contracted to carry out brain scans of Koios users to gauge the effects of the product. The brain-scan study could provide evidence that Koios products may enhance cognition over the long term, as well as helping the company improve its products’ formulations and performance (http://cnw.fm/h9sgF).
Market watchers believe that the nootropics industry will expand significantly over the next few years. MarketResearch.com predicts a 9.3 percent expansion of the function-enhancing beverage market by 2022 (http://cnw.fm/znQ6M). Nutraingredients.com cites BCC Research, which suggests that the market will reach $105.5 billion by 2021 (http://cnw.fm/d9Cqu).
Koios is poised to be a part of this growth, with an available distribution network featuring thousands of retail locations across the United States. The company has just opened up distribution into Canada via a global shipping program through its website.
“The idea of using nootropic supplements to help boost focus and mental acuity has been catching on with people around the world, not just in the United States. We have particularly been seeing increased demand for our products in Canada and are happy to be able to now meet that demand with our global shipping program,” Koios CEO Chris Miller said in a news release referencing the expansion into Canada.
The company has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, SportLife Distribution and Wishing-U-Well. Together, these distributors represent more than 80,000 bricks-and-mortar locations across the United States, from sports nutrition stores to large natural grocery chains including Whole Foods and Sunflower markets. Through its partnership with Wishing-U-Well, Koios also enjoys a large presence online, and its products are certified under the Amazon Choice Product program.
For more information, visit the company’s website at www.KoiosBeverageCorp.com
More from CannabisNewsWire
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
